Health geographer named new fellow of the UK’s Royal Society of Arts

Gavin J. Andrews, a professor in McMaster's Department of Health, Aging and Society, has been named a Fellow of the UK's Royal Society of Arts.

By Stacey Gabitous September 13, 2017

Gavin J. Andrews, a professor in McMaster's Department of Health, Aging and Society, has been named a Fellow of the UK's Royal Society of Arts.
Gavin J. Andrews, a professor in McMaster’s Department of Health, Aging and Society, has been named a Fellow of the UK’s Royal Society of Arts.

Expert Featured In This Story

Gavin Andrews
Gavin Andrews

Professor

See Profile

Gavin J. Andrews, a professor in McMaster’s Department of Health, Aging and Society, has been named a Fellow of the UK’s Royal Society of Arts (Royal Society for the encouragement of Arts, Manufactures and Commerce).

The Royal Society of Arts is made up of a global network of fellows – 28,000 admitted since its inception in 1754 – who have a broad mission to enrich society through ideas and action and research. Other fellows include, or have included, Charles Dickens, Adam Smith, Karl Marx, Stephen Hawking and Judi Dench.

Andrews, the Graduate Chair of the Department of Health, Aging & Society, is a leading health geographer. His wide-ranging research explores the dynamics between space, place and aging, holistic medicine, health care work, phobias, sports and fitness, health histories and popular music.

Most notably, his work has been influential in promoting an era of research in Health Geography that explores the physical and conscious unfolding of the environment. This opens up the possibility that energies and atmospheres are involved in health and well-being.

“I am proud to be awarded the RSA fellowship,” says Andrews. “It is an honour to be recognized on an international level for the research I’ve been doing.”

A couple walking on a path, one of them using a walker for assistance.

McMaster researchers identify genetic factors linked to frailty

Understanding what influences frailty opens the door to earlier screening and personalized approaches to supporting healthy aging, researchers say
A close-up of a vial containing a clear peptide blend of BPC-157 and TB-500, next to two single-use syringes.

What do we know about ‘research only’ peptides? Q&A with expert Stuart Phillips 

Unapproved peptides that lack safety and efficacy data carry substantial risks and belong in a laboratory, not your body, Phillips warns.
Scientist Jon Stokes stands in a university corridor, wearing a hoodie and ball cap.

McMaster researcher awarded more than $2M from Weston Family Foundation to advance precision antibiotic for IBD

The funding will accelerate the move toward human trials, enabling preclinical studies, regulatory preparation and early-phase clinical trial design.